- Search results for 1339928-25-4
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
3 products were found matching "1339928-25-4"!
Close filters
Filter by:
No results were found for the filter!
Item number: TGM-T2078-100mg
Description: Fimepinostat (CUDC 907) is an orally bioavailable inhibitor of both phosphoinositide 3-kinase (PI3K) class I and pan-histone deacetylase (HDAC) enzymes, with potential antineoplastic activity. Upon oral administration, CUDC-907 inhibits the activity of both PI3K class I isoforms and HDAC, thereby...
Keywords: | CUDC-907, PI3K/HDAC Inhibitor, CUDC 907 |
Application: | Targets histone deacetylase 1/2 [EC:3.5.1.98] (HDAC1_2) |
CAS | 1339928-25-4 |
MW: | 508.55 D |
From 40.00€
*
Item number: LKT-C8112.1
CUDC-907 is an inhibitor of PI3K and class I and II histone deacetylases (HDACs). This compound exhibits anticancer chemotherapeutic activity, inhibiting cell proliferation and tumor growth in a variety of cancer models.
Application: | PI3K / HDAC inhibitor |
CAS | 1339928-25-4 |
MW: | 508.55 D |
From 138.00€
*
Item number: Cay25651-5
CUDC-907 is a dual inhibitor of HDACs and phosphatidylinositol 3-kinases (PI3Ks). It inhibits HDAC activity in HeLa nuclear extracts (IC50 = 50s = 50s = 2/M phase and apoptosis and decreases cellular migration and invasion in FTC-133, THJ-29T, XTC-1, and 8505C thyroid cancer cell lines in a concentration-dependent...
Keywords: | N-hydroxy-2-[[[2-(6-methoxy-3-pyridinyl)-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]methylamino]-5-pyrimidinecarb... |
Application: | PI3K & HDAC inhibitor |
CAS | 1339928-25-4 |
MW: | 508.6 D |
From 164.00€
*